Legend Biotech Corp (LEGN) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Legend Biotech Corp stock $14.82, price $15.99, that is 7.3% below the price, quality 39 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Legend Biotech Corp
LEGN · USThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range $15.99 – $76.50 · fair‑value band $11.11 – $18.52 · the $15.99 price screens above the $14.82 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Legend Biotech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
Show moreShow less
Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer.
In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China.
The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Stock analysis
Legend Biotech Corp (LEGN) currently trades at $15.99, while our estimate is $14.82, so the stock looks roughly fairly valued today (gap 7.9%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $11.11 (bear) to $18.52 (bull), the price of $15.99 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Legend Biotech Corp reported revenue of $1.0B in FY2025 versus $68.8M in FY2021, a compound +96.6%/yr. Reported net income was −$297M in FY2025.
Key figures
Market cap $3.2B Mid · P/S ratio 3.12 · EPS (TTM) $−0.0200 · Net margin −28.8% · Return on equity −8.1% · Return on assets (EBIT) −23.8% (5-year average) · Operating margin 14.9% · Revenue (TTM) $1.3B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 24 out of 100 (low confidence).
What moves the price
The share trades about 56% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −7%, LEGN screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch LEGN, get fair value alerts →
Recent news
- Is Legend Biotech (LEGN) Reasonable After CARVYKTI Sales Growth?
- Legend Biotech's Carvykti Positioned to Sustain Growth Into 2027, RBC Capital Markets Says
- Legend Biotech Corp (LEGN) Q3 2026 Earnings Call Highlights: CARVYKTI Sales Jump 36% as ...
- Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights
Compare Legend Biotech Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 847 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs LEGN |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs LEGN |
| Samsung Biologics Co 207940 | 1,423,000 KRW | 1,552,100 KRW | +9% | vs LEGN |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs LEGN |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs LEGN |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs LEGN |
| BeOne Medicines AG 6160 | HK$249.40 | HK$152.92 | −39% | vs LEGN |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs LEGN |
| Celltrion, Inc 068270 | 214,500 KRW | 74,945 KRW | −65% | vs LEGN |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs LEGN |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Legend Biotech Corp (LEGN) overvalued or undervalued?
What is the fair value of LEGN?
What is the quality score of LEGN?
What is the price target for Legend Biotech Corp (LEGN)?
What is the Legend Biotech Corp stock forecast for 2026?
What is the revenue of Legend Biotech Corp (LEGN)?
What is the intrinsic value of Legend Biotech Corp (LEGN)?
Is Legend Biotech Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LEGN?
How much is Legend Biotech Corp worth?
What do the bullish and bearish scenarios say about LEGN?
How solid is the balance sheet of Legend Biotech Corp (LEGN)?
How far is LEGN from its 52-week high?
Which stocks are comparable to Legend Biotech Corp?
Is Legend Biotech Corp stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Legend Biotech Corp (LEGN)?
What should I pay attention to with Legend Biotech Corp right now?
Key figures of Legend Biotech Corp
How large is the market capitalisation of Legend Biotech Corp (LEGN)?
What is the P/S ratio of Legend Biotech Corp (LEGN)?
What are the earnings per share of Legend Biotech Corp (LEGN)?
What is the net margin of Legend Biotech Corp (LEGN)?
What is the return on equity of Legend Biotech Corp (LEGN)?
What is the EBIT return on assets of Legend Biotech Corp (LEGN)?
What is the operating margin of Legend Biotech Corp (LEGN)?
How fast is revenue growing at Legend Biotech Corp (LEGN)?
How much free cash flow does Legend Biotech Corp (LEGN) generate?
How much net cash does Legend Biotech Corp (LEGN) hold?
Watch Legend Biotech Corp in the live analysis
One click puts Legend Biotech Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.